XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Redeemable Convertible Preferred Stock
Preferred Stock
Common Stock Subject to Possible Redemption
Common Stock [Member]
Previously Reported
Previously Reported
Common Stock [Member]
Previously Reported
Treasury Stock
Previously Reported
Additional Paid-In Capital
Previously Reported
Accumulated Deficit
Previously Reported
Redeemable Convertible Preferred Stock
Retroactive Application of Recapitalization
Retroactive Application of Recapitalization
Common Stock [Member]
Retroactive Application of Recapitalization
Treasury Stock
Retroactive Application of Recapitalization
Additional Paid-In Capital
Retroactive Application of Recapitalization
Redeemable Convertible Preferred Stock
Adjusted Balance
Adjusted Balance
Common Stock [Member]
Adjusted Balance
Additional Paid-In Capital
Adjusted Balance
Accumulated Deficit
Balance at the beginning (in shares) at Dec. 31, 2022   6,143,294 124,225     16,498,279                                
Balance at the beginning at Dec. 31, 2022 $ (70,539) $ 0 $ 0 $ 209,928 $ (280,467) $ 64,020                                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Exercise of stock options (in shares) 1,000 1,000                                        
Exercise of stock options (in dollars) $ 1     1                                    
Reissuance of Shadow Preferred in Pay-to-Play Pull Through Exchange at redemption value (In dollars) (109,327)     (109,327)   $ 109,327                                
Reissuance of Shadow Preferred in Pay-to-Play Pull Through Exchange at redemption value (in shares)   (2,799,634)       27,996,424                                
Reissuance of common stock in common rights offering (in shares)   8,109,693                                        
Issuance of common stock upon release of restricted stock units   6,000,000                                        
Pay-to-Play financing charges 35,771     35,771                                    
Debt financing charge on convertible notes 2,640     2,640                                    
Stock-based compensation 2,483     2,483                                    
Net loss (87,589)       (87,589)                                  
Balance at the ending at Dec. 31, 2023 $ (226,560) $ 0 $ 0 141,496 (368,056) $ 173,347   $ (226,560)     $ 141,496 $ (368,056) $ 173,347           $ (53,213) $ 5 $ 314,838 $ (368,056)
Balance at the ending (in shares) at Dec. 31, 2023   17,454,353 124,225     44,494,703     13,613,269       34,712,525             48,325,794    
Balance at the beginning outstanding (in shares) at Dec. 31, 2023 124,225                 96,887                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Retroactive application of recapitalization (in shares)                             34,712,525 (96,887)   (34,712,525)        
Retroactive application of recapitalization (in dollars)                           $ 173,347 $ 5   $ 173,342 $ (173,347)        
Exercise of stock options (in shares)   27,821                                        
Exercise of stock options (in dollars) $ 80     80                                    
Stock-based compensation 1,042     1,042                                    
Net loss (54,503)       (54,503)                                  
Balance at the ending at Sep. 30, 2024 $ (106,594) $ 5   315,960 (422,559)                                  
Balance at the ending (in shares) at Sep. 30, 2024   48,353,615                                        
Balance at the beginning (in shares) at Dec. 31, 2023   17,454,353 124,225     44,494,703     13,613,269       34,712,525             48,325,794    
Balance at the beginning outstanding (in shares) at Dec. 31, 2023 124,225                 96,887                        
Balance at the beginning at Dec. 31, 2023 $ (226,560) $ 0 $ 0 141,496 (368,056) $ 173,347   (226,560)     141,496 (368,056) $ 173,347           (53,213) $ 5 314,838 (368,056)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Exercise of stock options (in shares) 65,646 65,646                                        
Exercise of stock options (in dollars) $ 98     98                                    
Stock-based compensation 3,847     3,847                                    
Net loss (61,195)       (61,195)                                  
Balance at the ending at Dec. 31, 2024 (283,810) $ 0 $ 0 145,441 (429,251) $ 173,347   (283,810)     145,441 (429,251) $ 173,347           (110,463) $ 5 318,783 (429,251)
Balance at the ending (in shares) at Dec. 31, 2024   17,519,999 124,225     44,494,703     13,663,527       34,712,525             48,376,052    
Balance at the beginning (in shares) at Jun. 30, 2024                 13,633,706       34,712,525             48,346,231    
Balance at the beginning outstanding (in shares) at Jun. 30, 2024                   96,887                        
Balance at the beginning at Jun. 30, 2024               (254,731)     142,221 (396,952) $ 173,347           (81,384) $ 5 315,563 (396,952)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Retroactive application of recapitalization (in shares)                             34,712,525 (96,887)   (34,712,525)        
Retroactive application of recapitalization (in dollars)                           173,347 $ 5   173,342 $ (173,347)        
Exercise of stock options (in shares)   7,384                                        
Exercise of stock options (in dollars) 38     38                                    
Stock-based compensation 359     359                                    
Net loss (25,607)       (25,607)                                  
Balance at the ending at Sep. 30, 2024 $ (106,594) $ 5   315,960 (422,559)                                  
Balance at the ending (in shares) at Sep. 30, 2024   48,353,615                                        
Balance at the beginning (in shares) at Dec. 31, 2024   17,519,999 124,225     44,494,703     13,663,527       34,712,525             48,376,052    
Balance at the beginning outstanding (in shares) at Dec. 31, 2024 124,225                 96,887                        
Balance at the beginning at Dec. 31, 2024 $ (283,810) $ 0 $ 0 145,441 (429,251) $ 173,347   (283,810)     145,441 (429,251) $ 173,347           $ (110,463) $ 5 $ 318,783 $ (429,251)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Retroactive application of recapitalization (in shares)                             34,712,525 (96,887)   (34,712,525)        
Retroactive application of recapitalization (in dollars)                           $ 173,347 $ 5   $ 173,342 $ (173,347)        
Conversion of convertible notes (in shares)   31,433,259                                        
Conversion of convertible notes (in dollars) 314,334 $ 3   314,331                                    
Net exercise of warrants (in shares)   7,505,657                                        
Net exercise of warrants (in dollars) 75,057 $ 1   75,056                                    
Payment of Shareholder note receivable 200     200                                    
Issuance of common stock to advisors, Shares   873,486                                        
Issuance of common stock to advisors, Value 2,538     2,538                                    
Issuance of common stock warrants 167     167                                    
Increase in redemption value             $ 603                              
Exercise of stock options (in shares)   15,080                                        
Exercise of stock options (in dollars) 18     18                                    
Temporary equity Merger and PIPE financing, Shares             2,854,242                              
Temporary equity Merger and PIPE financing, Value             $ 33,061                              
Merger and PIPE financing (in shares)   11,408,957                                        
Merger and PIPE financing (in dollars) (126,164) $ 1   (126,165)                                    
Redemption of common stock subject to possible redemption, Shares             (2,800,489)                              
Redemption of common stock subject to possible redemption, Value             $ (33,157)                              
Temporary equity Lapse of redemption, Shares             (53,753)                              
Temporary equity Lapse of redemption, Value             $ (507)                              
Lapse of redemption, Shares   53,753                                        
Lapse of redemption,Value 503     503                                    
Releases of restricted stock units (in shares)   1,331,257                                        
Common stock issued under the committed equity facility (in shares)   5,673,734                                        
Common stock issued under the committed equity facility (in dollars) 20,389 $ 1   20,388                                    
Committed equity facility fee settled in common stock (in shares)   83,353                                        
Committed equity facility fee settled in common stock (in dollars) 243     243                                    
Stock-based compensation 28,092     28,092                                    
Net loss (203,608)       (203,608)                                  
Balance at the ending at Sep. 30, 2025 1,306 $ 11   634,154 (632,859)                                  
Balance at the ending (in shares) at Sep. 30, 2025   106,754,588                                        
Balance at the beginning (in shares) at Jun. 30, 2025                 98,881,933                          
Balance at the beginning at Jun. 30, 2025               $ (4,810) $ 10   $ 601,781 $ (606,601)                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Payment of Shareholder note receivable 0                                          
Issuance of common stock to advisors, Shares   769,231                                        
Issuance of common stock to advisors, Value 2,238     2,238                                    
Exercise of stock options (in shares)   15,080                                        
Exercise of stock options (in dollars) 18     18                                    
Releases of restricted stock units (in shares)   1,331,257                                        
Common stock issued under the committed equity facility (in shares)   5,673,734                                        
Common stock issued under the committed equity facility (in dollars) 20,389 $ 1   20,388                                    
Committed equity facility fee settled in common stock (in shares)   83,353                                        
Committed equity facility fee settled in common stock (in dollars) 243     243                                    
Stock-based compensation 9,486     9,486                                    
Net loss (26,258)       (26,258)                                  
Balance at the ending at Sep. 30, 2025 $ 1,306 $ 11   $ 634,154 $ (632,859)                                  
Balance at the ending (in shares) at Sep. 30, 2025   106,754,588